the company’s diabetes franchise is seeing elevated growth and a substantial improvement in the immunohematology and quality control businesses. Bio-Rad recently launched the IH-500 next ...
Bio-Rad develops products and solutions for the life sciences research and clinical diagnostic markets and enjoys niche market leadership in diagnostic quality controls, antigens, and digital ...
the company’s diabetes franchise is seeing elevated growth and a substantial improvement in the immunohematology and quality control businesses. Bio-Rad recently launched the IH-500 next ...
--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE ... was primarily driven by an increased demand for our quality control and blood typing products. Currency neutral sales increased in EMEA ...